Comparing two ways to help the stomach empty after esophagus surgery
Compares Botox injection with pyloromyotomy in adults having esophagus surgery.
Key facts
- Who runs it
- The Cleveland Clinic
- Where
- Cleveland, United StatesSee the site
- Trial code
- Registry title
- Effectiveness of Methods for Pyloric Drainage in esophagecTomY: Botox vs. Pyloromyotomy
- Status
- Recruiting
- Phase
- Phase 2/3
- People taking part
- 170 people, planned
- Started
- 3 Dec 2024
- Expected to end
- 31 May 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Botulinum Toxin A (Botox )
- Pyloromyotomy
- Record updated
- 25 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who are having a planned esophagectomy (surgery to remove the esophagus) and will have their stomach used to rebuild the food pathway. It compares two ways of helping the stomach empty: a Botox injection into the pylorus or a pyloromyotomy.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Planned (elective) esophagectomy with a gastric conduit for reconstruction, for benign or malignant esophageal disease. The surgeon must be able to do either method during the operation.
Main reasons for not taking part
- Emergency esophagectomy (for example, for a perforated esophagus)
- Neuromuscular disease such as amyotrophic lateral sclerosis, myasthenia gravis, muscular dystrophies or Lambert-Eaton syndrome
- Sweet esophagectomy without a left neck incision
- Pregnancy
- Allergy or hypersensitivity to botulinum toxin
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- 18 years of age or older
- Undergoing elective esophagectomy (thoracoabdominal, Ivor-Lewis, McKeown)
- Receiving a gastric conduit for alimentary reconstruction
- Technically able to receive either intrapyloric Botox injection or pyloromyotomy as ultimately determined intraoperatively
- Willing and able to provide informed consent
- Willing and able to participate in long-term follow up including study visits and surveys
Who cannot take part
- Patients undergoing left thoracoabdominal without left cervical neck incision (i.e., Sweet esophagectomy) - excluded due to the extent of gastric resection
- Undergoing emergent esophagectomy (e.g., for esophageal perforation)
- Patients with underlying neuromuscular disease as Botox would be contraindicated (amyotrophic lateral sclerosis, myasthenia gravis, muscular dystrophies, Lambert-Eaton syndrome)
- Allergy or hypersensitivity to botulinum toxin
- Pregnancy
- Cannot feasibly receive both pyloric interventions as determined intraoperatively (e.g., patients with central obesity undergoing thoracoabdominal esophagectomy makes for a technically difficult pyloromyotomy)
Where in United States
- Cleveland ClinicCleveland, United StatesContact: Andrew Conner, MDTaking people
About the trial
What the trial wants to find out
The goal of this pragmatic, registry-based, randomized clinical trial is to find out if using botulinum toxin (Botox) to help drain the stomach during an esophagectomy works as well as a pyloromyotomy in patients undergoing elective esophagectomy for benign or malignant esophageal disease. Both methods are intended to prevent problems with food emptying too slowly from the stomach (delayed gastric emptying), which can cause discomfort after surgery. The main question it aims to answer is:
Read full original descriptionShow less
Is intrapyloric Botox injection as a drainage procedure during esophagectomy non-inferior in preventing symptoms of delayed gastric emptying at 6 months postoperatively compared to pyloromyotomy?
Researchers will compare intrapyloric Botox injection to pyloromyotomy to see if Botox is non-inferior to pyloromyotomy in easing symptoms of delayed gastric emptying.
Participants will:
Be randomized to one of two treatment groups-either intrapyloric Botox injection or pyloromyotomy-during their esophagectomy.
Complete surveys assessing digestive symptoms at standard postoperative follow-up intervals (3 months, 6 months, 1 year, and 2 years postoperatively).
Undergo a standard gastric emptying study at 6 months after surgery.
The 2 groups in the trial
- BotoxTreatment being tested
Patients will be randomized to the intrapyloric Botox injection intervention arm intraoperatively just after the pylorus is identified and just prior to the time at which pyloric drainage would occur routinely, at which point it is feasible for the surgeon to perform either intervention.
Treatment: Botulinum Toxin A (Botox )
- PyloromyotomyExisting treatment, for comparison
Patients will be randomized to the pyloromyotomy intervention arm intraoperatively just after the pylorus is identified and just prior to the time at which pyloric drainage would occur routinely, at which point it is feasible for the surgeon to perform either intervention.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparative Effectiveness of Intrapyloric Botulinum Toxin Injection Versus Pyloromyotomy for Pyloric Drainage During Esophagectomy: A Registry-Based, Pragmatic Randomized Noninferiority Trial
- Plain-language title
- Comparing two ways to help the stomach empty after esophagus surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 25 February 2026